• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Annexon, Inc. - common stock (NQ:ANNX)

    4.720 -0.480 (-9.23%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,627,039
    Open 5.150
    Bid (Size) 4.730 (400)
    Ask (Size) 5.580 (1,000)
    Prev. Close 5.200
    Today's Range 4.675 - 5.300
    52wk Range 1.850 - 7.180
    Shares Outstanding 47,722,995
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead ↗
    Annexon (NASDAQ:ANNX) executives used a Goldman Sachs Healthcare Conference session to outline the company’s upcoming clinical and regulatory catalysts, led by pivotal Phase III data expected in the... 
    Via MarketBeat
    News headline image
    Annexon Maps 3 Big Pipeline Catalysts Ahead of Q4 Vision-Drug Readout ↗
    Annexon (NASDAQ:ANNX) executives outlined a series of expected clinical and regulatory updates across the company’s complement-focused pipeline during a session at the Jefferies Conference,... 
    Via MarketBeat

    Performance

    YTD
    +0.6%
    +0.6%
    1 Month
    -16.9%
    -16.9%
    3 Month
    -22.4%
    -22.4%
    6 Month
    -2.9%
    -2.9%
    1 Year
    +82.2%
    +82.2%

    More News

    Read More
    News headline image
    Annexon to Participate in Upcoming June Investor Conferences
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Highlights Q4 Geographic Atrophy Data, GBS Filing Plans at BofA Conference ↗
    Via MarketBeat
    News headline image
    Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon to Present at the Bank of America Securities Health Care Conference 2026
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Biogen Acquires Apellis Pharmaceuticals in $5.6 Billion Deal After Clinical Success
    Via MarketMinute
    News headline image
    Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    Curious about the stocks that are showing activity after the closing bell on Monday? ↗
    Via Chartmill
    News headline image
    Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Which stocks are moving on Wednesday? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    Annexon Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
    From Annexon Biosciences
    Via GlobeNewswire

    Frequently Asked Questions

    Is Annexon, Inc. - common stock publicly traded?
    Yes, Annexon, Inc. - common stock is publicly traded.
    What exchange does Annexon, Inc. - common stock trade on?
    Annexon, Inc. - common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Annexon, Inc. - common stock?
    The ticker symbol for Annexon, Inc. - common stock is ANNX on the Nasdaq Stock Market
    What is the current price of Annexon, Inc. - common stock?
    The current price of Annexon, Inc. - common stock is 4.720
    When was Annexon, Inc. - common stock last traded?
    The last trade of Annexon, Inc. - common stock was at 06/10/26 04:00 PM ET
    What is the market capitalization of Annexon, Inc. - common stock?
    The market capitalization of Annexon, Inc. - common stock is 225.25M
    How many shares of Annexon, Inc. - common stock are outstanding?
    Annexon, Inc. - common stock has 225M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.